o Asian American woman has exercised management responsibility over as large, prestigious and as dynamic a business Christine Poon. As Worldwide Chairman of Johnson & Johnson's pharmaceuticals group Christine Poon manages the biggest division of the Fortune 500's Number 30 company. Under Poon's leadership, since November 2000 J&J acquired five pharmaceutical companies and now gets over half of its $43 billion annual sales from Tylenol, Motrin and a long list of less famous medicines under Poon's division. By comparison, J&J's more famous consumer products division accounts for only 9% and its medical devices group for 36% of total revenues. In recognition of her success in leading J&J's drive to grow its global pharmaceuticals group to the level of giants like Merck, Pfizer, GlaxoSmithKline and Novartis, in Poon was recently named a Johnson & Johnson Vice Chairman.
Christine Poon grew up in Cincinatti. She graduated a year early from Northwestern University with a degree in biology. She worked briefly as a lab technician at USC before returning for a masters in biology and biochemistry from St. Louis University. The prospect of bigger paychecks motivated Poon to acquire an MBA from Boston University while working as a manager at New England Nuclear.
o Asian American woman has exercised management responsibility over as large, prestigious and as dynamic a business Christine Poon. As Worldwide Chairman of Johnson & Johnson's pharmaceuticals group Christine Poon manages the biggest division of the Fortune 500's Number 30 company. Under Poon's leadership, since November 2000 J&J acquired five pharmaceutical companies and now gets over half of its $43 billion annual sales from Tylenol, Motrin and a long list of less famous medicines under Poon's division. By comparison, J&J's more famous consumer products division accounts for only 9% and its medical devices group for 36% of total revenues. In recognition of her success in leading J&J's drive to grow its global pharmaceuticals group to the level of giants like Merck, Pfizer, GlaxoSmithKline and Novartis, in Poon was recently named a Johnson & Johnson Vice Chairman.
